Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272319 · ClinicalTrials.gov registry record
Genetic Collection Protocol
A clinical trial of Liver Diseases, sponsored by Arbor Research Collaborative for Health.
- Recruiting
- Registry status
- 2,230
- Enrollment target
- 13
- Study locations
NCT05272319 is a study of Liver Diseases that is actively recruiting participants, run by Arbor Research Collaborative for Health. The registered enrollment target is 2,230 participants, below the 61,091-participant average among 33 other Liver Diseases trials with a reported enrollment target (96% lower). The trial reports 13 study locations across 11 states.
The verdict
NCT05272319, a study of Liver Diseases, is actively recruiting participants, sponsored by Arbor Research Collaborative for Health.
- RECRUITING
- Registry status
- 2,230 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.
Conditions Studied
Study Locations (13)
California
- Children's Hospital of Los Angeles - Los Angeles
- UCSF Benioff Children's Hospital - San Francisco
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Children's Healthcare of Atlanta - Atlanta
Illinois
- Lurie Children's Hospital - Chicago
Indiana
- Riley Hospital for Children - Indianapolis
Ohio
- Cincinnati Children's Hospital - Cincinnati
Texas
- Texas Children's Hospital; Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,230 participants |
| Start Date | 2022-04-06 |
| Est. Completion | 2029-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05272319
The ClinicalTrials.gov registry entry for NCT05272319 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61,091-participant average among 33 other Liver Diseases trials with a reported enrollment target (96% lower). The listed sponsor is Arbor Research Collaborative for Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT05272319 reports 13 study locations spanning 11 distinct geographic areas - top geographies include California, Pennsylvania, Colorado.
Frequently Asked Questions
What is clinical trial NCT05272319 about?
NCT05272319 is a clinical study titled "Genetic Collection Protocol". This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.
What is the current status of trial NCT05272319?
This trial is currently recruiting. The enrollment target is 2,230 participants. The study started on 2022-04-06. Estimated completion is 2029-05-31.
What conditions does trial NCT05272319 study?
This clinical trial studies the following conditions: Liver Diseases.
Who is sponsoring clinical trial NCT05272319?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05272319 being conducted?
This trial has 13 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
RECRUITING · NA
-
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
RECRUITING · NA
-
MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
RECRUITING
-
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
RECRUITING · Phase 1
-
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
RECRUITING · NA
-
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.